Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Frequency of use and adequacy of Cochrane risk of bias tool 2 in non-Cochrane systematic reviews published in 2020: Meta-research study.
Res Synth Methods. 2024 May;15(3):430-440. doi: 10.1002/jrsm.1695. Epub 2024 Jan 23.
Res Synth Methods. 2024.
PMID: 38262609
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases.
Galusic D, Basic-Kinda S, Pijuk A, Milunovic V, Dreta B, Franjic N, Coha B, Sincic-Petricevic J, Gacina P, Pejsa V, Lucijanic M, Aurer I.
Galusic D, et al. Among authors: pijuk a.
Hemasphere. 2022 Nov 15;6(12):e807. doi: 10.1097/HS9.0000000000000807. eCollection 2022 Dec.
Hemasphere. 2022.
PMID: 36407092
Free PMC article.
Item in Clipboard
The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.
Babic A, Pijuk A, Brázdilová L, Georgieva Y, Raposo Pereira MA, Poklepovic Pericic T, Puljak L.
Babic A, et al. Among authors: pijuk a.
BMC Med Res Methodol. 2019 Apr 11;19(1):77. doi: 10.1186/s12874-019-0718-8.
BMC Med Res Methodol. 2019.
PMID: 30971219
Free PMC article.
Item in Clipboard
Cite
Cite